US HB5723 | 2017-2018 | 115th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 4-1)
Status: Engrossed on June 20 2018 - 50% progression, died in committee
Action: 2018-06-20 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on June 20 2018 - 50% progression, died in committee
Action: 2018-06-20 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Expanding Oversight of Opioid Prescribing and Payment Act of 2018 (Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.
Title
Expanding Oversight of Opioid Prescribing and Payment Act of 2018
Sponsors
Rep. Claudia Tenney [R-NY] | Rep. David McKinley [R-WV] | Rep. Suzan DelBene [D-WA] | Rep. James Renacci [R-OH] |
Rep. Mark Sanford [R-SC] |
History
Date | Chamber | Action |
---|---|---|
2018-06-20 | Senate | Received in the Senate and Read twice and referred to the Committee on Finance. |
2018-06-19 | House | Motion to reconsider laid on the table Agreed to without objection. |
2018-06-19 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264) |
2018-06-19 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 5723. |
2018-06-19 | House | Considered under suspension of the rules. (consideration: CR H5264-5265) |
2018-06-19 | House | Mr. Roskam moved to suspend the rules and pass the bill, as amended. |
2018-06-19 | House | Placed on the Union Calendar, Calendar No. 592. |
2018-06-19 | House | Committee on Energy and Commerce discharged. |
2018-06-19 | House | Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I. |
2018-05-22 | House | Referred to the Subcommittee on Health. |
2018-05-16 | House | Ordered to be Reported (Amended) by Voice Vote. |
2018-05-16 | House | Committee Consideration and Mark-up Session Held. |
2018-05-09 | House | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2018-05-09 | House | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2018-05-09 | House | Introduced in House |
Same As/Similar To
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
Congressional oversight
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health
Health information and medical records
Home and outpatient care
Hospital care
Medicare
Prescription drugs
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health
Health information and medical records
Home and outpatient care
Hospital care
Medicare
Prescription drugs